Precise Evaluation - The Smart Creation Medical and AMH Program Helped the Middle East Reproductive Center Improve IVF Success Rate

Customer Background
Region: Middle East (a well-known reproductive medicine center in the UAE)
Institution Type: Private specialized infertility (IVF) hospital
Purchase Objective: To find a highly sensitive, point-of-care (POCT) AMH (anti-Müllerian hormone) testing solution for evaluating female ovarian reserve function.

Challenges
Long testing cycle: Previously, samples needed to be sent to a centralized laboratory, and the report cycle was 3-5 days. This severely delayed the timeliness for the IVF process that requires real-time adjustment of the ovulation induction plan.
High sample stability requirements: AMH is sensitive to the testing environment, and long-distance transportation can cause data fluctuations, affecting clinical decisions.
Patient anxiety: Patients in high-end private hospitals have extremely high requirements for testing timeliness and privacy protection, hoping to receive the assessment results on the same day of the outpatient visit.
Jiachuang Jiuhe Customized Solution
We provided a "high-sensitivity fluorescence + intelligent quantification" closed-loop solution: 
Core product: AMH Anti-Mullerian Hormone Quantitative Detection Kit (Fluorescence Immunoassay Strip Method).

Core advantages:
Ultra-fast quantification: With the AFS-1000 fluorescence analyzer, precise quantitative values (ng/mL) can be obtained in just 15 minutes.
Compared to gold standards: The test results have a correlation of over 98% with mainstream large-scale luminescence equipment, ensuring clinical significance.
Minimal sample volume: Only a small amount of blood sample is required, reducing the pain for patients during blood collection.
Professional delivery: Through the international platform, "expert-to-expert" remote installation training is provided to ensure that the hospital laboratory can quickly master the standard operating procedures (SOP).

Delivery outcomes
400% improvement in outpatient efficiency: Achieve "on-site testing", allowing doctors to formulate preliminary ovulation induction plans based on AMH results during the same day of consultation.
IVF conversion rate increase: Due to the ability to provide more timely personalized diagnosis and treatment suggestions, the center's IVF weekly conversion rate increased by 15% in this quarter.
Brand reputation upgrade: The hospital, with the "instant reproductive health assessment" feature, attracted more high-end commercial insurance clients, and the monthly outpatient volume significantly increased.
"The AMH solution of JiaChuangJiuHe He has solved our most troublesome issue of timeliness. The accuracy and stability of the AFS-1000 instrument exceeded our expectations."